Salgenx Unveils Revolutionary Saltwater Redox Flow Battery for Grid-Scale Energy Storage
Salgenx, a division of Infinity Turbine LLC, is proud to announce the launch of its groundbreaking saltwater redox flow battery, offering a sustainable and cost-effective alternative to traditional lithium-ion batteries for grid-scale energy storage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203440827/en/
Salgenx Grid Scale 3000 kWh MegaWatt Pack Battery (Photo: Business Wire)
Key Advantages of Salgenx's Saltwater Redox Flow Battery:
- Enhanced Safety: Utilizing non-flammable, non-toxic materials, the saltwater battery significantly reduces risks associated with thermal runaway and fires, ensuring safer operation compared to lithium-ion counterparts.
- Environmental Sustainability: Constructed from abundant and eco-friendly materials including biochar from bamboo, the battery minimizes environmental impact and simplifies recycling processes, promoting a circular economy approach.
- Cost-Effectiveness: The use of widely available resources leads to lower production costs, making it a financially viable solution for large-scale energy storage needs.
- Scalability and Durability: Designed for easy scalability, the battery can be expanded to meet growing energy demands. Its robust architecture ensures a long cycle life with deep discharge capabilities, providing reliable performance over time.
Innovative Applications:
Beyond energy storage, the Salgenx saltwater redox flow battery offers multifunctional capabilities, including:
- Desalination: Simultaneously produces fresh water during the charging process, addressing water scarcity issues.
- Thermal Storage: The benefit of a grid-scale flow battery is the ability to simultaneously store hot or cold water, making it a Thermal Energy Storage (TES) device. Each battery can hold up to 48,000 liters of liquid thermal energy.
These unique features position the Salgenx battery as a versatile solution for various industrial applications, enhancing its value proposition in the energy storage market.
Grid-Scale Capacity:
The Salgenx system is engineered for large-scale energy storage, making it ideal for utility companies and renewable energy integration. Its modular design allows for seamless expansion, catering to diverse energy requirements and contributing to grid stability and resilience.
About Salgenx:
Salgenx, a division of Infinity Turbine LLC, specializes in innovative energy storage solutions. Committed to sustainability and technological advancement, Salgenx develops cutting-edge products that address the evolving needs of the energy sector.
Saltwater Battery Website: https://salgenx.com
Infinity Turbine Website: https://www.infinityturbine.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241203440827/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Eurobank Collaborates with LTIMindtree for a Multi-Year Banking Technology Program17.2.2025 09:30:00 CET | Press release
Cements relationship with the opening of Global Delivery Center in Pune, India Eurobank S.A. (“Eurobank”), a subsidiary of “Eurobank Ergasias Services and Holdings S.A.” (“Eurobank Holdings”) a leading banking group in Athens, Greece and LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, have joined forces to initiate a multi-year mutually beneficial cooperation focused on enhancing customer experience by improving banking operations and building innovative IT services for Eurobank and its subsidiaries. The collaboration has been enabled by Fairfax Digital Services (A Fairfax Company) andwill include the establishment of a Global Delivery Center in India. Global Delivery Center, Pune – Executing a shared vision Strengthening the commitment to innovation, customer experience, and excellence in banking technology, Eurobank & LTIMindtree, powered by Fairfax Digital Services, officially inaugurated their new Global Delivery Center at the LTI
ATP Media Selects SES for Tennis Content Delivery Worldwide17.2.2025 08:50:00 CET | Press release
SES SCORE platform and hybrid distribution to power broadcasts of 58 ATP tournaments that reach a billion global fans through 70+ broadcast partners SES announced today a new agreement to deliver and manage video content for ATP Tour events around the world using Secure Reliable Transport (SRT) and its unique Sports Content Orchestration Enabler (SES SCORE) platform enabled by SES’s hybrid IP, fibre and satellite distribution network. With more than 200,000 hours of live content per year from 3,200 tennis matches across various ATP Masters 1000, ATP 500 and ATP 250 tournaments, SES SCORE gives ATP Media an easy-to-use, centralized platform to manage and deliver its content. ATP Media’s 70+ broadcast partners can select from a variety of video feeds, audio, metadata and other content when creating their broadcasts with a simplified booking process. “We wanted to give our broadcast partners unrestricted access to up to 10 Court Feeds we produce at our ATP Masters 1000 tournaments, as wel
Textron Aviation to Open New Service Facility at Essendon Fields Airport, Expanding Capabilities in Australia17.2.2025 06:00:00 CET | Press release
Textron Aviation announced today an expansion of its footprint in Australia with the construction of a larger and modernized service facility at Essendon Fields Airport in Melbourne to maximize support for Cessna, Beechcraft and Hawker customers in the region. The new facility will add more space for servicing aircraft, aiding in faster scheduling with minimal down time to keep customers flying. Construction is set to begin March 2025 and Textron Aviation expects to be fully functional in the new facility by early 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213028444/en/ L-R: Stefan Wenger, vice president, International Customer Service Centers, Textron Aviation, Brian Rohloff, senior vice president, Global Customer Support, Textron Aviation, Brendan Pihan, CEO, Essendon Fields Airport, Peter Funder, general manager development, Essendon Fields Airport at the new facility site in Melbourne. (Photo: Craig Moodie)
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)16.2.2025 00:00:00 CET | Press release
OBODENCE™ and XBRYK™ approved by the European Commission (EC) for all indications referencing Prolia and Xgeva, respectivelyMarks Samsung Bioepis’ 10th and 11th product and first endocrinology treatment approved by the EC – adding to its growing portfolio of biosimilars Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars referencing Prolia and Xgeva – formerly referred to as SB16. OBODENCE, referencing Prolia, has been approved for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures, treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures, and treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture. XBRYK, referencing Xgeva, has been approved for the prevention of skel
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)15.2.2025 00:50:00 CET | Press release
In the MOTION Phase 3 study, ROMVIMZA met primary endpoint of improved objective response rate (ORR) compared to placebo and all key secondary endpoints with statistically significant and clinically meaningful improvements in quality-of-life measures, and demonstrated well-tolerated safety profile Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase inhibitor, for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause worsening functional limitation or severe morbidity. The FDA previously granted Fast Track designation and Priority Review for ROMVIMZA, which was developed by Deciphera Pharmaceuticals, Inc. (“Deciphera”), a wholly owned subsidiary of Ono. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250214768549/en/ “
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom